Moneycontrol
Moneycontrol PRO
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
MARKETS

Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE044A01036 | SECTOR: Pharmaceuticals & Drugs

| BSE 1733.75 9.30 (0.54%) | |

BSE Live

Feb 23, 16:00
1733.75 9.30 (0.54%)
Volume
AVERAGE VOLUME
5-Day
38,110
10-Day
41,633
30-Day
156,133
338,934

  • Prev. Close

    1724.45

  • Open Price

    1726.45

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Feb 23, 15:59
1732.30 7.90 (0.46%)
Volume
AVERAGE VOLUME
5-Day
1,242,820
10-Day
1,301,460
30-Day
2,676,898
1,550,400

  • Prev. Close

    1724.40

  • Open Price

    1732.90

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    1732.30 (149)

Financials

Cash Flow of Sun Pharmaceutical Industries (in Rs. Cr.) Mar 15 Mar 14 Mar 13 Mar 12 Mar 11  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax -1,558.97 -2,801.09 663.03 1,725.83 1,453.98  
Net CashFlow From Operating Activities 148.59 -2,405.06 106.48 1,339.18 1,223.34  
Net Cash Used In Investing Activities 2,152.81 519.14 460.54 -773.69 -1,062.69  
Net Cash Used From Financing Activities -2,674.09 1,742.10 -508.99 -420.21 -311.58  
Foreign Exchange Gains / Losses 1.64 -1.67 -4.94 3.06 -1.94  
Adjustments On Amalgamation Merger Demerger Others 487.93 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents 116.88 -145.49 53.09 148.34 -152.87  
Cash And Cash Equivalents Begin of Year 76.32 221.81 168.72 20.38 173.25  
Cash And Cash Equivalents End Of Year 193.20 76.32 221.81 168.72 20.38  
Source : Dion Global Solutions Limited

Results of Sun Pharma

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
Close Parallel Income Plan 2026